PART I Item 1. B usiness Overview Atara Biotherapeutics is a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune disease. Tab-cel (tabelecleucel), has received marketing authorization approval under the proprietary name Ebvallo by the European Commission (EC) for commercial sale and use in the European Economic Area (EEA), by the Medicines and Healthcare products Regul...
Q2 FY2026 — expected 2026-09-09
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-16 | 2025-12-31 | 0001193125-26-108361 | EDGAR | 106K words |
| 2025-03-07 | 2024-12-31 | 0000950170-25-035507 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0000950170-24-037644 | EDGAR | — |
| 2023-02-08 | 2022-12-31 | 0000950170-23-002185 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0001564590-22-007633 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001564590-21-009854 | EDGAR | — |
| 2020-02-27 | 2019-12-31 | 0001564590-20-007027 | EDGAR | — |
| 2019-02-26 | 2018-12-31 | 0001564590-19-004275 | EDGAR | — |
| 2018-02-27 | 2017-12-31 | 0001564590-18-003390 | EDGAR | — |
| 2017-03-09 | 2016-12-31 | 0001564590-17-003792 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-12 | 2025-09-30 | 0001193125-25-276219 | EDGAR | 71K words |
| 2025-08-11 | 2025-06-30 | 0000950170-25-106550 | EDGAR | — |
| 2025-05-15 | 2025-03-31 | 0000950170-25-072040 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-125389 | EDGAR | — |
| 2024-08-12 | 2024-06-30 | 0000950170-24-095533 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-056959 | EDGAR | — |
| 2023-11-01 | 2023-09-30 | 0000950170-23-057147 | EDGAR | — |
| 2023-08-08 | 2023-06-30 | 0000950170-23-039820 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0000950170-23-018820 | EDGAR | — |
| 2022-11-08 | 2022-09-30 | 0000950170-22-023248 | EDGAR | — |
| 2022-08-08 | 2022-06-30 | 0000950170-22-015536 | EDGAR | — |
| 2022-05-05 | 2022-03-31 | 0001564590-22-018253 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-16 | 0001193125-26-108344 | EDGAR | 2K words |
| 2026-03-12 | 0001193125-26-103127 | EDGAR | — |
| 2026-03-03 | 0001193125-26-086793 | EDGAR | — |
| 2026-02-23 | 0001193125-26-062534 | EDGAR | — |
| 2026-01-12 | 0001193125-26-010342 | EDGAR | — |
| 2026-01-02 | 0001193125-26-000907 | EDGAR | — |
| 2025-11-12 | 0001193125-25-276209 | EDGAR | — |
| 2025-10-07 | 0001193125-25-232117 | EDGAR | — |
| 2025-09-04 | 0000950170-25-112898 | EDGAR | — |
| 2025-08-11 | 0000950170-25-106533 | EDGAR | — |
216 total filings indexed. 184 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001604464 |
| Ticker | ATRA |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.atarabio.com |
| Listed | 2014-10-16 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ATRA (~200 tokens, structured JSON with cryptographic provenance)